-The Hindu If we are going to buy American, why not adopt the American way of giving local bodies the right to refuse entry to super stores in their area There is the United States of America and then there is the ‘idea’ of USA that exists in the minds of significant portions of the middle classes all across the globe. How this looks in real life varies slightly according to the...
More »SEARCH RESULT
A short-sighted cap-Chandra M Gulhati
-The Indian Express The government’s proposal to price-control certain drugs will create more problems than it will solve From clothes to cars, prices of consumer products the world over are determined taking into account input costs, margins and competition, popularly called the cost-based pricing system. Departing from this sound, fair, tried and tested principle of commerce, the government’s new drug pricing policy, approved by the Group of Ministers headed by Sharad Pawar,...
More »FDI in retail must be measured by benefits for consumer & economy, not just for farmers
-The Economic Times The recent decision of the government to allow FDI in multi-brand retail trade has attracted heated debate and emotive reactions. Though the main consideration for allowing FDI in retail is not its benefit for farm sector, the debate has predominantly focused on threats and benefits to the country's farmers and the farm sector. Interestingly, the main stakeholders, i.e., farmers, have not reacted much to the policy decision and...
More »Govt to bring essential medicines under price control -Kounteya Sinha
-The Times of India India will, for the first time, put a cap on the maximum price at which essential drugs, like some commonly used anti-AIDS and anti-cancer drugs, besides a horde of painkillers, anti-TB drugs, sedatives, lipid lowering agents and steroids, can be sold in the country. In a landmark decision, a group of ministers (GoM) headed by agriculture minister Sharad Pawar on Thursday cleared the proposal to bring all 348...
More »Panel backs market say in drug prices
-The Telegraph A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines. The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments — from painkillers and antibiotics to asthma medications and drugs against high blood...
More »